Kuiper, Justine L <br/><br/>
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor.  [electronic resource] 

 -  Journal of clinical pathology  Apr 2015 
 - 320-1 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1472-4146 
<br/><br/><label>Standard No.: </label>10.1136/jclinpath-2015-202866  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Biopsy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--enzymology<br/>DNA Mutational Analysis<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Fatal Outcome<br/>Female<br/>Genetic Predisposition to Disease<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Mutation<br/>Phenotype<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--therapeutic use<br/>Time Factors<br/>Treatment Outcome